Innovent and SanegeneBio collaborate to develop siRNA drug for treatment of hypertension
Innovent also obtains an exclusive option to license in the future development, manufacturing and commercialization rights of SGB-3908
Innovent also obtains an exclusive option to license in the future development, manufacturing and commercialization rights of SGB-3908
This combination aims to offer an effective tool to manage symptoms of nausea and vomiting during pregnancy
MedTech Mitra is a platform that will help the young talents of the country by holding their hands and giving them final shape to their research, knowledge and logic
NEIAFMR to be developed as the national hub for folk medicine
Astellas has acquired abiraterone decanoate being developed by Propella to treat prostate cancer
The LyondellBasell CirculenRenew polymers are made from renewable feedstocks derived from bio-based wastes
The establishment of the facility demonstrates the company's commitment to delivering differentiated solutions to gynecology and pediatrics challenges
US FDA approval based on NEURO-TTRansform Phase III results
BioVaxys has been granted exclusivity while the parties work in good faith on the drafting of a definitive agreement
The plant is yet to start commercial operations
Subscribe To Our Newsletter & Stay Updated